HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Susan D. Moffatt-Bruce Patrick Ross Alexandru M. Vaida Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moffatt-Bruce, S. D. Articles by Hitchcock, C. L. Search for Related Content PubMed PubMed Citation Articles by Moffatt-Bruce, S. D. Articles by Hitchcock, C. L. Related Collections Lung - cancer Related Article

---

Original Articles: General Thoracic

Comparative Mutational Profiling in the Assessment of Lung Lesions: Should It Be the Standard of Care?

^a Division of Cardiothoracic Surgery, Department of Surgery, Ohio State University, Columbus, Ohio
^b Division of Thoracic Pathology, Department of Pathology, Ohio State University, Columbus, Ohio
^c RedPath Integrated Pathology, Pittsburgh, Pennsylvania

Accepted for publication March 16, 2010.

^_* Address correspondence to Dr Moffatt-Bruce, Ohio State University Medical Center, N835 Doan Hall, 410 W 10th Ave, Columbus, OH 43210 (Email: susan.moffatt-bruce{at}osumc.edu).

Background: Discerning primary versus metastatic lung lesions is problematic. Comparative mutational profiling (CMP) involves genetic and point mutation analysis of lesions to facilitate this. We sought to review our experience in cases of two lung lesions or head and neck cancer and lung lesions to determine whether a significantly clinical problem existed, what standard processes were in place to address it, and whether a new diagnostic standard was required.

Methods: Between January 1, 2007, and October 31, 2008, CMP was used in 24 cases of two lung lesions or a head and neck cancer and lung lesion. Routine hematoxylin and eosin stain examination and immunohistochemistry were performed as appropriate. The CMP involved DNA sequencing for specific oncogene point mutations and a panel of allelic imbalance markers. Metastatic cancer required demonstration of concordant mutations affecting the same allele copy in different cancer deposits.

Results: The patient mean age was 62 years; there were 13 men and 11 women. The cases involved two lung lesions (n = 13) or a head and neck cancer and a lung lesion (n = 11). Standard pathology examination was unable to discriminate the lesions, and they were subsequently differentiated by CMP. Fifteen discordant CMP results were interpreted as independent primaries; 9 cases were concordant, consistent with metastatic disease.

Conclusions: Discerning primary versus metastatic disease when dealing with lung lesions is a clinically significant problem. Comparative mutational profiling was found to be useful and reliable to assess the relatedness of multiple cancer lesions when routine pathology assessment was unable to.

Related Article

Invited Commentary

Bernhard C. Danner
Ann. Thorac. Surg. 2010 90: 397. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				B. C. Danner Invited Commentary Ann. Thorac. Surg., August 1, 2010; 90(2): 397 - 397. [Full Text] [PDF]